ARCHIVES

FDA Approves New Drug for Advanced Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 30 No. 5 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

Full Funding Of Indirect Costs, Other Mandates By Congress Chew Up Most Of NCI’s Extra Money

December 2, 1983

Saffiotti Quits As Carcinogenesis Chief With Blast At Rauscher, Peters

April 30, 1976

Judah Folkman, Angiogenesis Pioneer, Dead at 74.

January 18, 2008

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999

NCI-Approved Clinical Trials

July 28, 2006